4-83309479-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM1BS2
The NM_001098540.3(HPSE):c.907C>T(p.Arg303Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000068 in 1,543,224 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000059 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000069 ( 2 hom. )
Consequence
HPSE
NM_001098540.3 missense
NM_001098540.3 missense
Scores
3
9
7
Clinical Significance
Conservation
PhyloP100: 1.98
Genes affected
HPSE (HGNC:5164): (heparanase) Heparan sulfate proteoglycans are major components of the basement membrane and extracellular matrix. The protein encoded by this gene is an enzyme that cleaves heparan sulfate proteoglycans to permit cell movement through remodeling of the extracellular matrix. In addition, this cleavage can release bioactive molecules from the extracellular matrix. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM1
In a binding_site (size 0) in uniprot entity HPSE_HUMAN
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HPSE | NM_001098540.3 | c.907C>T | p.Arg303Trp | missense_variant | 7/12 | ENST00000311412.10 | NP_001092010.1 | |
HPSE | NM_006665.6 | c.907C>T | p.Arg303Trp | missense_variant | 8/13 | NP_006656.2 | ||
HPSE | NM_001199830.1 | c.733C>T | p.Arg245Trp | missense_variant | 6/11 | NP_001186759.1 | ||
HPSE | NM_001166498.3 | c.907C>T | p.Arg303Trp | missense_variant | 8/11 | NP_001159970.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPSE | ENST00000311412.10 | c.907C>T | p.Arg303Trp | missense_variant | 7/12 | 1 | NM_001098540.3 | ENSP00000308107 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152064Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
9
AN:
152064
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000156 AC: 37AN: 237234Hom.: 1 AF XY: 0.000164 AC XY: 21AN XY: 128124
GnomAD3 exomes
AF:
AC:
37
AN:
237234
Hom.:
AF XY:
AC XY:
21
AN XY:
128124
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000690 AC: 96AN: 1391042Hom.: 2 Cov.: 24 AF XY: 0.0000820 AC XY: 57AN XY: 694832
GnomAD4 exome
AF:
AC:
96
AN:
1391042
Hom.:
Cov.:
24
AF XY:
AC XY:
57
AN XY:
694832
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152182Hom.: 0 Cov.: 33 AF XY: 0.0000806 AC XY: 6AN XY: 74396
GnomAD4 genome
AF:
AC:
9
AN:
152182
Hom.:
Cov.:
33
AF XY:
AC XY:
6
AN XY:
74396
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
25
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 29, 2024 | The c.907C>T (p.R303W) alteration is located in exon 8 (coding exon 7) of the HPSE gene. This alteration results from a C to T substitution at nucleotide position 907, causing the arginine (R) at amino acid position 303 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;D;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M;M;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Benign
T
PROVEAN
Pathogenic
D;D;D;D
REVEL
Uncertain
Sift
Pathogenic
D;D;D;D
Sift4G
Uncertain
D;D;D;D
Polyphen
D;D;.;.
Vest4
MutPred
Loss of ubiquitination at K307 (P = 0.0364);Loss of ubiquitination at K307 (P = 0.0364);Loss of ubiquitination at K307 (P = 0.0364);.;
MVP
MPC
0.49
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at